1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, S; Liang, XJ; Ma, X; Wang, H; Wu, Y | 1 |
| Cossu, F; Melis, G; Rombi, G | 1 |
2 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Breast Neoplasms
| Article | Year |
|---|---|
Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Methacrylates; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Phosphatidylethanolamines; Xenograft Model Antitumor Assays | 2012 |
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |